Publications found:
51,015
Sort by:
2014 Analysis of the US Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
620 pages
2014 Analysis of the US Respiratory Disease Testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 3,680.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, ...
November 2013
282 pages
2014 Analysis of the US Enteric Disease Testing Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 4,320.00
... , sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, ...
November 2013
314 pages
US Lung Cancer Drug Pipeline Analysis
US$ 1,800.00
... annual statistics published, an estimated 201,144 people in the United States were diagnosed with lung cancer. This figure included 107,164 men and ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Lung Cancer Drug Pipeline Analysis ...
November 2013
385 pages
US Colorectal Cancer Drug Pipeline Analysis
US$ 1,500.00
... that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Colorectal Cancer Drug Pipeline ...
November 2013
242 pages
US Parkinson's Disease Drug Pipeline Analysis
US$ 1,500.00
... in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Parkinson’s Disease Drug Pipeline Analysis ...
November 2013
241 pages
Plastic Headgear Market in United States to 2017 - Market Size, Trends, and Forecasts
US$ 664.00
... 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for ... key questions such as: What is the size of the plastic headgear market in United States? How is the market divided into different product segments? ...
October 2013
13 pages
Regeneron - Eylea’s Growth Potential and Pipeline is Lucrative Enough!
US$ 140.00
... of Eylea (aflibercept, VEGF-Trap Eye, L, wet-AMD, Central Retinal Vein Occlusion – CRVO, partnered with Bayer for ex-US) in Diabetic Macular Edema (DME) and myopic choroidal neovascularization (mCNV) and promise of the late-stage pipeline esp. anti-PCSK9 mAb, Alirocumab (REGN727, PhIII, Hypercholesterolemia ...
October 2013
7 pages
2014 U.S. Automobile & Other Vehicles Wholesale Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Automobile & Other Vehicles Wholesale Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate industry ... , establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ratios, number of firms, ...
October 2013
202 pages
2014 U.S. Automobile Gas Engine & Engine Parts Mfg. Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Automobile Gas Engine & Engine Parts Manufacturing Industry-Industry & Market report, published annually by Barnes Reports, contains timely and ... size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ...
October 2013
134 pages
2014 U.S. Automobile Parts & Supplies Wholesales Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Automobile Parts & Supplies Wholesales Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate industry ... of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ...
October 2013
220 pages
2014 U.S. Breakfast Cereal Manufacturing Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Breakfast Cereal Manufacturing Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate industry statistics, ... cereal, and corn and wheat flakes. New for 2014! Barnes Reports has published its 2014 U.S. Economic Forecast. The Forecast includes written ...
October 2013
56 pages
2014 U.S. Electronic Shopping & Mail Order Houses Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Electronic Shopping & Mail Order Houses Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate ... the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ...
October 2013
220 pages
2014 U.S. Fitness & Recreational Sports Centers Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Fitness & Recreational Sports Centers Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate industry ... of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ...
October 2013
249 pages
2014 U.S. Household & Institutional Furniture Mfg. Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Household & Institutional Furniture Manufacturing Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate industry ... , chairs, beds and bars. New for 2014! Barnes Reports has published its 2014 U.S. Economic Forecast. The Forecast includes written ...
October 2013
196 pages
2014 U.S. Marketing Research & Public Opinion Polling Industry-Industry & Market Report
US$ 149.00
The 2014 U.S. Marketing Research & Public Opinion Polling Industry-Industry & Market report, published annually by Barnes Reports, contains timely and accurate ... size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and over 900 metro areas. Other data include financial ...
October 2013
135 pages
Incyte- INCB39110 – Another JAK-Fruit in INCY’s Basket
US$ 140.00
... RA – Xeljanz) and in light of current competition in plaque psoriasis market. For more detail, please read our report on INCY, released on Oct. 3, 2013, titled, 'INCB39110 – Another JAK-Fruit in INCY ...
October 2013
5 pages
Merck Update: HCV combo, Lambrolizumab and Corporate Restructuring Program
US$ 90.00
Merck announced restructuring (cost efficiency) program which is likely to ... by 2015) announced by the Company through workforce reduction across all functional divisions, head quarter relocation, out ... . More focused attention on therapy areas where Merck has proven its abilities irrespective of unmet need ...
October 2013
3 pages
US Orphan Drug Pipeline Analysis
US$ 1,800.00
... from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the ... increasing, thus increasing the profit margins in the future. “US Orphan Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ...
October 2013
880 pages
US Alzheimer Drug Pipeline Analysis
US$ 2,000.00
... observed that almost 1 in 8 people coming under the 65+ age group are patients of Alzeimer’s disease. Amongst the population in the 80+ age group, almost ... market based upon development process. Following parameters for each drug profile in development phase are covered in “US Alzheimer Drug Pipeline Analysis” ...
October 2013
348 pages
US Prostate Cancer Drug Pipeline Analysis
US$ 1,800.00
... Clinical Trial Owner / Originator/ Licensee/Collaborator Administrative Route Drug Class ATC Codes US Prostate Cancer Drug Pipeline by Clinical Phase: Research: 11 Preclinical: 44 Unknown Phase: 4 Phase 0: 1 Phase-I: 22 Phase-I/II: 18 Phase-II: 53 Phase-II/III: 1 Phase-III:14 Marketed: 13
October 2013
375 pages
US Breast Cancer Drug Pipeline Analysis
US$ 1,800.00
... and new therapies would account for more than 25% of the overall market for breast cancer drug treatments. “US Breast Cancer Drug Pipeline Analysis” by ... drug market based upon development process. Following parameters for each drug profile in development phase are covered in “US Breast Cancer Drug Pipeline ...
October 2013
480 pages
US Steel Industry Outlook to 2017
US$ 1,200.00
... . In their latest research report, “US Steel Industry Outlook to 2017”, RNCOS analysts have identified that the US steel industry has been playing an ... these, the research includes trends and drivers prevailing in the US steel industry. The report is an outcome of comprehensive research and unbiased analysis ...
October 2013
130 pages
2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets
US$ 9,200.00
Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500 “2014 Opportunities in the US Clinical Chemistry and Immunodiagnostics Markets” is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the ...
September 2013
600 pages
Generic Advair - 3 years to go, but which generic companies are better poised?
US$ 140.00
... announced the draft guidance for the development of generic version of GSK’s Asthma / COPD drug – Advair (Fluticasone propionate + Salmeterol Xinafoate). The ... guidelines pave the way for generic companies to launch a substitutable and interchangeable version of Advair in the US market, which should ...
September 2013
3 pages
US Proton Therapy Outlook 2017
US$ 2,000.00
... to make it more accessible to patients. According to the “US Proton Therapy Outlook 2017” by RNCOS, the United States will be home to almost 27 such centers ... will breach the Billion dollar mark to attain revenue of US$ 1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer ...
September 2013
65 pages
Onconova Therapeutics (ONTX) -Near-Term Catalysts = Upside Still!
US$ 200.00
Onconova Therapeutics (ONTX) debut on NASDAQ (IPO: ... in pts with 2nd-line Higher Risk MDS vs. less than six months offered ... ). Our risk reward analysis indicates that ONTX's lead drug, Estybon (Rigosertib/ ON ... our report on Onconova released on 30th August 2013, titled, "Near-Term Catalysts = Upside Still!"
August 2013
11 pages
Lime Market in United States to 2017 - Market Size, Trends, and Forecasts
US$ 653.00
... 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for ... KEY QUESTIONS SUCH AS: What is the size of the lime market in United States? How is the market divided into different product segments? Which products ...
August 2013
14 pages
